Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Telomere Shortening | 2 | 2021 | 33 | 0.810 |
Why?
|
| Sirtuins | 1 | 2019 | 20 | 0.640 |
Why?
|
| Liver Cirrhosis | 2 | 2021 | 834 | 0.510 |
Why?
|
| Mitochondria | 4 | 2017 | 692 | 0.430 |
Why?
|
| Telomere | 3 | 2021 | 212 | 0.410 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 189 | 0.360 |
Why?
|
| Telomerase | 3 | 2019 | 160 | 0.320 |
Why?
|
| Chromatin | 2 | 2022 | 555 | 0.300 |
Why?
|
| Aging | 2 | 2012 | 1189 | 0.290 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 724 | 0.290 |
Why?
|
| Telomere Homeostasis | 2 | 2019 | 42 | 0.250 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2024 | 37 | 0.220 |
Why?
|
| Collagen Type VI | 1 | 2021 | 4 | 0.190 |
Why?
|
| Hepatic Stellate Cells | 1 | 2021 | 21 | 0.190 |
Why?
|
| Protein Subunits | 1 | 2021 | 165 | 0.180 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2021 | 129 | 0.180 |
Why?
|
| Multiple Myeloma | 1 | 2022 | 173 | 0.180 |
Why?
|
| Cullin Proteins | 1 | 2020 | 14 | 0.180 |
Why?
|
| Hematopoiesis | 1 | 2021 | 220 | 0.170 |
Why?
|
| Fibrosis | 1 | 2021 | 437 | 0.160 |
Why?
|
| Nicotinamide Mononucleotide | 1 | 2019 | 5 | 0.160 |
Why?
|
| Mitochondria, Liver | 1 | 2019 | 31 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 198 | 0.160 |
Why?
|
| Claudins | 1 | 2018 | 29 | 0.160 |
Why?
|
| Sirtuin 1 | 1 | 2019 | 46 | 0.160 |
Why?
|
| Muscle Proteins | 2 | 2018 | 418 | 0.150 |
Why?
|
| Cells, Cultured | 3 | 2021 | 3061 | 0.150 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2011 | 153 | 0.150 |
Why?
|
| Mitosis | 1 | 2018 | 237 | 0.150 |
Why?
|
| Peptides | 1 | 2021 | 794 | 0.150 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 258 | 0.150 |
Why?
|
| Glioblastoma | 2 | 2012 | 334 | 0.140 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 215 | 0.140 |
Why?
|
| Cell Movement | 2 | 2018 | 835 | 0.140 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 456 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2019 | 701 | 0.130 |
Why?
|
| Animals | 13 | 2021 | 34200 | 0.130 |
Why?
|
| Phenylbutyrates | 1 | 2017 | 58 | 0.130 |
Why?
|
| HEK293 Cells | 1 | 2019 | 753 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 4431 | 0.130 |
Why?
|
| Mice | 10 | 2021 | 17757 | 0.120 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2017 | 235 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 1899 | 0.120 |
Why?
|
| Signal Transduction | 6 | 2021 | 4543 | 0.120 |
Why?
|
| p21-Activated Kinases | 2 | 2018 | 58 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 2 | 2011 | 687 | 0.110 |
Why?
|
| RNA-Binding Proteins | 2 | 2024 | 577 | 0.110 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 2060 | 0.100 |
Why?
|
| Genes, Essential | 1 | 2012 | 41 | 0.100 |
Why?
|
| Liver | 1 | 2019 | 1764 | 0.090 |
Why?
|
| Genes, myc | 2 | 2022 | 100 | 0.090 |
Why?
|
| Mice, Knockout | 1 | 2019 | 3754 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 953 | 0.090 |
Why?
|
| Oxidative Stress | 2 | 2017 | 807 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 189 | 0.090 |
Why?
|
| Sequence Deletion | 1 | 2012 | 528 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 355 | 0.080 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2011 | 146 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 3 | 2018 | 354 | 0.080 |
Why?
|
| Cell Proliferation | 4 | 2021 | 2307 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2010 | 195 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2011 | 444 | 0.080 |
Why?
|
| Pancreatic Ducts | 1 | 2008 | 21 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2024 | 543 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2020 | 2610 | 0.080 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2008 | 67 | 0.070 |
Why?
|
| Mice, Nude | 3 | 2018 | 711 | 0.070 |
Why?
|
| Autophagy | 1 | 2011 | 395 | 0.070 |
Why?
|
| Models, Biological | 1 | 2012 | 1461 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 2513 | 0.070 |
Why?
|
| Humans | 12 | 2022 | 124802 | 0.070 |
Why?
|
| Reactive Oxygen Species | 3 | 2017 | 492 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2010 | 1929 | 0.060 |
Why?
|
| Stem Cells | 1 | 2010 | 702 | 0.060 |
Why?
|
| Cyclophilin A | 1 | 2024 | 16 | 0.060 |
Why?
|
| Nuclear Proteins | 2 | 2021 | 1272 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2017 | 384 | 0.050 |
Why?
|
| Mutation | 1 | 2017 | 5814 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 1240 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 3342 | 0.050 |
Why?
|
| Proteasome Inhibitors | 1 | 2022 | 61 | 0.050 |
Why?
|
| Apoptosis | 2 | 2021 | 1792 | 0.050 |
Why?
|
| Cell Self Renewal | 1 | 2021 | 44 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2021 | 135 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 266 | 0.050 |
Why?
|
| Megakaryocytes | 1 | 2021 | 43 | 0.050 |
Why?
|
| Superoxide Dismutase | 2 | 2012 | 138 | 0.050 |
Why?
|
| Interferons | 1 | 2021 | 124 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2021 | 116 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2020 | 142 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2020 | 174 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2021 | 405 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 170 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2012 | 467 | 0.040 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2018 | 7 | 0.040 |
Why?
|
| Snail Family Transcription Factors | 1 | 2018 | 23 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 275 | 0.040 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2018 | 25 | 0.040 |
Why?
|
| Twist-Related Protein 1 | 1 | 2018 | 36 | 0.040 |
Why?
|
| Phenotype | 3 | 2017 | 4260 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2018 | 70 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2020 | 809 | 0.040 |
Why?
|
| Vimentin | 1 | 2018 | 66 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2012 | 612 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 356 | 0.040 |
Why?
|
| Heterografts | 1 | 2018 | 178 | 0.040 |
Why?
|
| Proteogenomics | 1 | 2018 | 67 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2020 | 677 | 0.040 |
Why?
|
| Male | 3 | 2019 | 61302 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 355 | 0.040 |
Why?
|
| Receptors, Estrogen | 2 | 2012 | 796 | 0.040 |
Why?
|
| DNA Damage | 2 | 2011 | 516 | 0.040 |
Why?
|
| Calsequestrin | 1 | 2017 | 12 | 0.040 |
Why?
|
| Female | 3 | 2019 | 66575 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 121 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1749 | 0.030 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2018 | 235 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2017 | 242 | 0.030 |
Why?
|
| Proteomics | 1 | 2018 | 500 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1704 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 3690 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 1626 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2018 | 820 | 0.030 |
Why?
|
| Phosphonoacetic Acid | 1 | 2012 | 2 | 0.030 |
Why?
|
| Hydroxamic Acids | 1 | 2012 | 56 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2012 | 31 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2012 | 1668 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2012 | 25 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2012 | 140 | 0.020 |
Why?
|
| Calcium | 1 | 2017 | 1099 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 375 | 0.020 |
Why?
|
| Cardiac Volume | 1 | 2011 | 17 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2012 | 95 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2017 | 1027 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 204 | 0.020 |
Why?
|
| Catalase | 1 | 2011 | 50 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2011 | 41 | 0.020 |
Why?
|
| Lymphoma, T-Cell | 1 | 2012 | 65 | 0.020 |
Why?
|
| Chloroquine | 1 | 2011 | 32 | 0.020 |
Why?
|
| Enzyme Reactivators | 1 | 2010 | 3 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 107 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2011 | 147 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2010 | 30 | 0.020 |
Why?
|
| Homozygote | 1 | 2012 | 534 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 255 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2010 | 58 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 670 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 436 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 265 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2010 | 132 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 435 | 0.020 |
Why?
|
| Smell | 1 | 2010 | 120 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2010 | 124 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 582 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 626 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 504 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2010 | 363 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 169 | 0.020 |
Why?
|
| Models, Animal | 1 | 2010 | 465 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 647 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 768 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 618 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 488 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 1473 | 0.010 |
Why?
|
| Genomics | 1 | 2008 | 1490 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 3143 | 0.010 |
Why?
|
| Brain | 1 | 2010 | 3010 | 0.010 |
Why?
|
| Neoplasms | 1 | 2012 | 2789 | 0.010 |
Why?
|